Janssen Biotech's proposed purchase of a Maryland biopharm firm could top $1B
May 02, 2018 at 16:11 PM EDT
The Johnson & Johnson subsidiary declined to disclose the purchase price. The company being acquired provided the details.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.